Name | AKTSIONERNOE OBSCHESTVO "APTEKA N220" |
|---|
INN | 8603148964 |
|---|
KPP | 860301001 |
|---|
OGRN | 1078603009968 |
|---|
OKPO | 45790407 |
|---|
FFSM | 33087-D |
|---|
Address | 628609, Khanty-mansiyskiy Avtonomnyy Okrug - Yugra, g. Nizhnevartovsk, ul. Lenina, d. D. 11 |
|---|
Phone | Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) |
Registration date | 22.10.2007 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 6 po Khanty-Mansiyskomu avtonomnomu okrugu - Yugre |
|---|
|
AO "APTEKA N220" (Khanty–Mansi Autonomous Okrug; INN 8603148964) was registered on 22 Oct 2007. The company's authorized capital as of July 1, 2012 was 23816200 rub. Type of ownership of AO "APTEKA N220" - Open joint-stock companies. Form of ownership of AO "APTEKA N220" - Municipal property. Principal activities of AO "APTEKA N220": retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2022
Net loss (RAS) of AO APTEKA N220 dropped over 2022 2.10 times to 9.43 million RUB from 19.82 million RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period by 15.03% to 200.44 million RUB from 235.88 million RUB in 2021; cost of goods sold decreased by 15.70% to 127.64 million RUB from 151.40 million RUB; sales loss decreased by 21.72% to 16.53 million RUB from 21.11 million RUB. 2021
Net loss (RA) of AO APTEKA N220 made up 19.82 million RUB over 2021 compared to net profit of 2.00 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 10.46% to 235.88 million RUB from 263.43 million RUB in 2020; cost of goods sold decreased by 9.28% to 151.40 million RUB from 166.89 million RUB; sales loss made up 21.11 million RUB compared to sales profit of 6.20 million RUB. 2020
Net profit (RAS) of AO APTEKA N220 grew over 2020 2.53 times to 2.00 million RUB from 788.00 thousand RUB over 2019, the company informed. Revenue decreased in the accounting period by 9.36% to 263.43 million RUB from 290.63 million RUB in 2019; cost of goods sold decreased by 10.81% to 166.89 million RUB from 187.11 million RUB; sales profit went up by 11.08% to 6.20 million RUB from 5.58 million RUB. 2019
Net profit (RAS) of AO APTEKA N220 dropped in 2019 by 31.12% to 788.00 thousand RUB from 1.14 million RUB over the same period in 2018, the company informed. Revenue remained in the accounting period at the same level and made up 290.63 million RUB compared to 289.90 million RUB 289.90 million RUB; cost of goods sold decreased by 2.94% to 187.11 million RUB from 192.78 million RUB; sales profit fell by 19.16% to 5.58 million RUB from 6.90 million RUB. 2018
Net profit (RAS) of AO APTEKA N220 grew over 2018 1.62 times to 1.14 million RUB from 704.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 9.04% to 289.90 million RUB from 265.88 million RUB over 2017; cost of goods sold grew by 7.63% to 192.78 million RUB from 179.12 million RUB; sales profit went up 2.98 times to 6.90 million RUB from 2.31 million RUB. 2017
Net profit (RAS) of AO APTEKA N220 dropped in 2017 22.34 times to 704.00 thousand RUB from 15.73 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 27.76% to 265.88 million RUB from 368.05 million RUB in 2016; cost of goods sold decreased by 28.59% to 179.12 million RUB from 250.84 million RUB; sales profit fell 6.27 times to 2.31 million RUB from 14.49 million RUB. 2016
Net profit (RAS) of APTEKA N220, OAO grew over 2016 by 32.88% to 15.73 million RUB from 11.84 million RUB over 2015, the company informed. Revenue decreased in the accounting period by 3.82% to 368.05 million RUB from 382.65 million RUB in 2015; cost of goods sold decreased by 5.34% to 250.84 million RUB from 264.98 million RUB; sales profit fell by 38.46% to 14.49 million RUB from 23.54 million RUB. 2014
Net profit (RAS) of APTEKA N220, OAO grew over 2014 1.95 times to 13.19 million RUB from 6.76 million RUB over 2013, the company informed. Revenue increased in the accounting period by 10.98% to 376.72 million RUB from 339.44 million RUB over 2013; cost of goods sold grew by 9.00% to 271.00 million RUB from 248.62 million RUB; sales profit went up 1.88 times to 19.13 million RUB from 10.17 million RUB. 2013
Net profit (RAS) of APTEKA N220, OAO dropped in 2013 by 48.60% to 6.76 million RUB from 13.15 million RUB over the same period in 2012, the company informed. Revenue increased in the accounting period by 6.11% to 339.44 million RUB from 319.89 million RUB over 2012; cost of goods sold grew by 7.13% to 248.62 million RUB from 232.07 million RUB; sales profit fell by 39.29% to 10.17 million RUB from 16.75 million RUB. 2012
Net profit (RAS) of Apteka N 220, OAO grew over 2012 3.27 times to 13.15 million RUB from 4.02 million RUB over 2011, the company informed. Cost of goods sold grew by 14.80% to 232.07 million RUB from 202.15 million RUB; sales profit went up 2.75 times to 16.75 million RUB from 6.10 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|